Medicare Enrolled
Dr. Scott Barkin, D.O.
Urology Physician · Gahanna, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barkin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barkin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barkin
Dr. Scott Barkin is an urology physician in Gahanna, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barkin performed 2,405 Medicare services across 1,352 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barkin received a total of $2,696 from 24 pharmaceutical and/or device companies across 75 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barkin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in OH
$2,696 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,405
Medicare services
Top 23% in OH for urology physician
1,352
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~120 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
520 | $85 | $268 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
400 | $47 | $185 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
293 | $7 | $158 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
153 | $46 | $182 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
146 | $35 | $139 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $58 | $197 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
75 | $52 | $426 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
63 | $8 | $31 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
58 | $61 | $183 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
57 | $18 | $63 |
| PSA test (prostate cancer screening) | 47 | $18 | $66 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
44 | $73 | $558 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
38 | $100 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $106 | $404 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
36 | $28 | $167 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
29 | $93 | $1,175 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $92 | $444 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
26 | $23 | $206 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $92 | $290 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
26 | $50 | $204 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $325 | $1,270 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $7 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $93 | $702 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $4 | $181 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
18 | $135 | $1,443 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $24 | $100 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
16 | $94 | $386 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $102 | $539 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
12 | $559 | $5,000 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
12 | $89 | $850 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
12 | $220 | $1,390 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
12 | $21 | $79 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
20.5% medium
76.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,696
Total received (2018-2024)
Avg $385/year across 7 years
Top 46% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
75
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,696 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$74
2023
$512
2022
$107
2021
$88
2020
$26
2019
$978
2018
$911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Laborie Medical Technologies Corp.
$30
ABBVIE INC.
$25
Sumitomo Pharma America, Inc.
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PROCEPT BioRobotics Corporation
$1,135
NeoTract Inc.
$624
Astellas Pharma US Inc
$307
Janssen Biotech, Inc.
$85
Endo Pharmaceuticals Inc.
$63
Myovant Sciences Inc.
$51
Myriad Genetic Laboratories, Inc.
$46
Sumitomo Pharma America, Inc.
$43
Axonics, Inc.
$34
Boston Scientific Corporation
$32
Laborie Medical Technologies Corp.
$30
GENZYME CORPORATION
$26
ABBVIE INC.
$25
Avadel Specialty Pharmaceuticals, LLC
$24
180 Medical, Inc.
$23
Dendreon Pharmaceuticals LLC
$20
Olympus America Inc.
$20
Teleflex LLC
$18
KARL STORZ Endoscopy-America
$17
Medtronic USA, Inc.
$17
Coloplast Corp
$16
Calyxo, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$14
GlaxoSmithKline, LLC.
$12
Top 3 companies account for 76.6% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AVEED · AquaBeam Robotic System · Axonics · BEXSERO · BOTOX · CVAC ASPIRATION SYSTEM · Erleada · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · GEMTESA · GENERAL PAIN MANAGEMENT · GENESIS · ICEfx Cryoablation System · ICONSYNC · JEVTANA · MYRBETRIQ · Myrbetriq · Noctiva · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · QUVIVIQ · UROLIFT · UroLift · VESICARE · XIAFLEX · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
99
Per 100K population
7.5
County median income
$73,795
Nearest hospital
MOUNT CARMEL NEW ALBANY SURGICAL HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barkin is a clinical cardiology specialist, with above-average Medicare volume (top 23% in OH), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barkin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Barkin performed 520 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barkin receive payments from pharmaceutical companies?
Yes. Dr. Barkin received a total of $2,696 from 24 companies across 75 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barkin's costs compare to other urology physicians in Gahanna?
Dr. Barkin's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barkin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Gahanna
Browse urology physicians in Gahanna ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology